Every recall we track for Zydus Pharmaceuticals (USA) Inc — 95 in all — plus the complaints and injury reports the public filed about them.
Zydus Pharmaceuticals recalls 25mg Mirabegron Extended-Release Tablets due to N-Nitroso impurity found in some batches. This may pose a risk to health. Affected products have specific lot numbers and expiration dates.
Zydus Pharmaceuticals recalls 250mg Erythromycin tablets with potential N-Nitroso-Desmethyl-Erythromycin above safe levels. Rx-only bottles from specific NDCs and lots may pose health risks.
Zydus Pharmaceuticals recalls 500mg erythromycin tablets with N-Nitroso-Desmethyl-Erythromycin above safe limits. Rx-only medication from India distributed in US. Stop using immediately.
Zydus Pharmaceuticals recalls Icosapent Ethyl capsules with red dots and melted capsules due to oxidized active ingredient. Stop using affected lots before 2027.
Zydus Pharmaceuticals recalls 1g Icosapent Ethyl capsules (NDC 70710-1592-07) due to oxidation from capsule leakage. Affected lots expire 2/2027 or 4/2027. Stop using if you have these capsules.
Zydus Pharmaceuticals recalls 100mg traZODONE tablets with a dent on the surface due to manufacturing defect. This may affect safety but does not cause serious injury. Check NDC 68382-806-10 and lot # EA00237A for affected units.
Zydus Pharmaceuticals recalls 5mg Bromocriptine Mesylate capsules due to detected impurities. Rx-only medication with specific lot numbers and expiration dates. Consumers should contact pharmacy for guidance.
Zydus Pharmaceuticals recalls 75mg clomipramine capsules due to nitrosamine impurities exceeding FDA limits. Affected lots have specific NDC numbers and expiration dates.
Zydus Pharmaceuticals recalls 50mg clomipramine capsules due to nitrosamine impurities exceeding FDA limits. This may pose health risks. Check NDC numbers and lot dates for affected products.
Zydus Pharmaceuticals recalls 25mg clomipramine capsules due to nitrosamine impurities exceeding FDA limits. These capsules may pose health risks. Consumers should check product details and contact the manufacturer.
Zydus Pharmaceuticals recalls 1mg Entecavir tablets due to failed impurity testing. This may pose health risks if used improperly. Consumers should contact the manufacturer for details.
Zydus Pharmaceuticals recalls 0.5mg Entecavir tablets due to failed impurity tests. This medication is prescription-only and may contain unsafe levels of organic impurities.
Zydus Pharmaceuticals recalls 0.5mg Entecavir tablets due to failed impurity tests. This may cause health risks. Contact for return instructions.
Zydus Pharmaceuticals recalls 1 mg Entecavir tablets due to failed impurity specifications. Patients should contact their doctor for guidance on safe use.
Zydus Pharmaceuticals recalls 10mg chlorpromazine tablets due to potential N-Nitroso Desmethyl Chlorpromazine contamination exceeding safe limits. Rx-only medication with specific NDC and lot numbers affected.
Zydus Pharmaceuticals recalls 200mg chlorpromazine tablets with N-Nitroso Desmethyl Chlorpromazine above safe limits. Rx-only medication from India distributed in US. Check NDC and lot numbers for affected batches.
Zydus Pharmaceuticals recalls 100mg Chlorpromazine tablets due to potential presence of N-Nitroso Desmethyl Chlorpromazine above safe limits. Rx-only medication with specific lot numbers and expiration dates.
Zydus Pharmaceuticals recalls 50mg Chlorpromazine tablets due to potential N-Nitroso Desmethyl Chlorpromazine contamination exceeding safe limits. Rx-only medication with specific lot numbers and expiration dates.
Zydus Pharmaceuticals recalls 200mg Chlorpromazine tablets due to potential N-Nitroso Desmethyl Chlorpromazine above safe levels. Rx-only medication with specific lot numbers and expiration dates.
Zydus Pharmaceuticals recalls 25mg Chlorpromazine tablets due to potential N-Nitroso Desmethyl Chlorpromazine contamination exceeding safe limits. Rx-only medication with specific lot numbers and expiration dates.
Zydus Pharmaceuticals recalls 25mg Chlorpromazine tablets due to potential N-Nitroso Desmethyl Chlorpromazine contamination exceeding safe levels. This prescription medication was manufactured in India and distributed in the US. Affected lots have specific expiration dates.
Zydus Pharmaceuticals recalls 100mg chlorpromazine tablets due to potential N-Nitroso Desmethyl Chlorpromazine contamination exceeding safe limits. Affected lots manufactured in India with specific expiration dates.
Zydus Pharmaceuticals recalls 10mg Chlorpromazine tablets due to potential N-Nitroso Desmethyl Chlorpromazine contamination exceeding safe limits. Rx-only medication from Zydus Lifesciences Ltd. in India.
Zydus Pharmaceuticals recalls 50mg chlorpromazine tablets due to potential N-Nitroso Desmethyl Chlorpromazine contamination exceeding safety limits. Affected lots from India and US distribution.
Zydus Pharmaceuticals recalls specific Succinylcholine Chloride Injection vials due to failed impurities tests. This medication, used for muscle relaxation during surgery, may contain harmful degradation products that could cause serious injury if used improperly.
Zydus Pharmaceuticals recalls Icosapent Ethyl capsules due to burnt or melted capsules from oxidation. Affected lots manufactured in Italy, distributed in the US. Stop using if capsules appear burnt or melted.
Zydus Pharmaceuticals recalls 40mg esomeprazole suspension due to impurities in long-term stability testing. This may cause health risks. Check NDC 68382-849-94 and lot numbers for affected products.
Zydus Pharmaceuticals recalls 20mg esomeprazole suspension due to impurities that could cause harm. Affected lots from M402147 to M502246 with specific expiration dates.
Zydus Pharmaceuticals recalls 10mg chlorpromazine tablets due to potential impurity levels exceeding safety limits. Affected lots manufactured in India with specific NDC and expiration date.
Zydus Pharmaceuticals recalls 75mg Venlafaxine tablets due to foreign material found in one tablet. This is a prescription-only product with specific lot numbers and expiration dates.
Zydus Pharmaceuticals recalls Nelarabine injection due to failed impurities and degradation specifications. This medication, used for cancer treatment, may have unsafe levels of impurities that could cause harm.
Zydus Pharmaceuticals recalls Nelarabine injection due to failed impurities and degradation. This medication, used for cancer treatment, may have harmful substances that could cause serious health issues if used.
Zydus Pharmaceuticals recalls 40mg esomeprazole suspension due to incorrect NDC number labeling. This affects prescription-only products sold in the US. No action is required as the product is safe but must be identified correctly.
Zydus Pharmaceuticals recalls Micafungin 100mg vials due to cross contamination risk. This affects specific lots manufactured for Northstar Rx LLC in Memphis, TN. Patients should contact their healthcare provider for guidance.
Zydus Pharmaceuticals recalls Micafungin 100mg vials due to cross contamination risk. This affects prescription-only injectable medication manufactured in India and distributed in the US. No specific remedy is listed in the recall notice.
Zydus Pharmaceuticals recalls Verapamil Hydrochloride Injection due to cross contamination risk. This medication is prescription-only and may be unsafe if contaminated.
Zydus Pharmaceuticals recalls estradiol transdermal patches (0.0375mg/day) due to failed impurities. Affected lots from India manufacturer Cadila Healthcare. Stop using if you have these specific lot numbers.
Zydus Pharmaceuticals recalls estradiol transdermal system (0.025mg/day) due to failed impurities and degradation. Rx-only product with specific lot numbers and expiration dates. Stop using immediately if affected.
Zydus Pharmaceuticals recalls 5mg Oxybutynin Chloride Extended-Release Tablets due to failed dissolution tests at 6 months. Affected products have NDC # 68382-255-01 and expire 11/2024.
Zydus Pharmaceuticals recalls 100 and 500-tablet Oxybutynin Chloride Extended-Release tablets due to failed dissolution specifications. This may affect medication effectiveness.
Zydus Pharmaceuticals recalls 0.6mg colchicine tablets due to failed impurities testing. Affected lots may contain unsafe levels of beta-lumicolchicine. Consumers should contact the manufacturer for details.
Zydus Pharmaceuticals recalls Fulvestrant injection due to failed impurities and degradation specifications. This prescription drug, sold in single-dose prefilled syringes, may pose health risks if used improperly.
Zydus Pharmaceuticals recalls 25mg Carvedilol tablets due to foreign paroxetine tablets found in some bottles. Report of two paroxetine tablets in the bottle poses a potential risk.
